mProX™ Human PRKAA1 Stable Cell Line
- Product Category:
- Membrane Protein Stable Cell Lines
- Subcategory:
- Kinase Cell Lines
To download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.
Lot Number
Made to Order Inquiry
InquiryProduct Information
Product Properties
Protocols
Please visit our protocols page.
Customer Reviews
Brady
Verified Customer
Matt
Verified Customer
Any questions about our products? Please visit our frequently asked questions page.
Published Data
Fig.1 Characteristics of cervical carcinoma cell lines.
AMPKα protein expression and activation were assessed via Western Blot analysis. Representative findings from three separate evaluations are displayed in membrane images. Densitometry between the reference gene and the studied gene is the basis for the quantitative results displayed on bar graphs.
Ref: Konieczny, Paweł, et al. "Impact of AMPK on cervical carcinoma progression and metastasis." Cell Death & Disease 14.1 (2023): 43.
Pubmed: 36658117
DOI: 10.1038/s41419-023-05583-9
Research Highlights
Genetic polymorphisms in PRKAA1, the catalytic subunit of AMP-activated protein kinase (AMPK), have been linked to an increased risk of gastric cancer. AMPK is a crucial enzyme that regulates cellular energy metabolism through phosphorylation.
Zhang, Yangmei, et al. "PRKAA1 promotes proliferation and inhibits apoptosis of gastric cancer cells through activating JNK1 and Akt pathways." Oncology research 28.3 (2020): 213.
Pubmed:
31558185
DOI:
10.3727/096504019X15668125347026
Large-scale, carefully planned case-control studies are needed to examine the association in order to validate the risk that the current meta-analysis found, particularly among non-Asian ethnicity.
Jiang, You, et al. "Association between PRKAA1 rs13361707 T> C polymorphism and gastric cancer risk: Evidence based on a meta-analysis." Medicine 97.14 (2018).
Pubmed:
29620653
DOI:
10.1097/MD.0000000000010302